Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-10
DOI
10.1038/s41416-020-01198-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging 18F-FDG PET Imaging Biomarkers in Patients with Esophageal Cancer
- (2018) Roelof J. Beukinga et al. RADIOLOGY
- An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients
- (2018) Hamid Asadzadeh Aghdaei et al. United European Gastroenterology Journal
- Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
- (2018) Concetta Panebianco et al. Microbiome
- Autophagy, Cancer Stem Cells & Drug Resistance
- (2018) Alexandra G. Smith et al. JOURNAL OF PATHOLOGY
- Positron-Emission Tomography Scan–Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography Nonresponders
- (2018) Megan Greally et al. Journal of Thoracic Oncology
- Gut microbiota modulation of chemotherapy efficacy and toxicity
- (2017) James L. Alexander et al. Nature Reviews Gastroenterology & Hepatology
- Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
- (2017) Leore T. Geller et al. SCIENCE
- Analysis ofFusobacteriumpersistence and antibiotic response in colorectal cancer
- (2017) Susan Bullman et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy
- (2017) Yung-Cheng Huang et al. BMC MEDICAL IMAGING
- Highly sensitive stool DNA testing ofFusobacterium nucleatumas a marker for detection of colorectal tumours in a Japanese population
- (2017) Yutaka Suehiro et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc
- (2016) Jawad Abed et al. Cell Host & Microbe
- Fusobacterium nucleatum infection of gingival epithelial cells leads to NLRP3 inflammasome-dependent secretion of IL-1β and the danger signals ASC and HMGB1
- (2016) Fiona Q. Bui et al. CELLULAR MICROBIOLOGY
- Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis
- (2016) Kensuke Yamamura et al. CLINICAL CANCER RESEARCH
- Identification of a lung cancer cell line deficient in atg7-dependent autophagy
- (2015) Jonathan Mandelbaum et al. Autophagy
- Fusobacterium nucleatum
- (2015) Arif Bashir et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model
- (2015) Q.-F. Gui et al. GENETICS AND MOLECULAR RESEARCH
- Tumor/normal esophagus ratio in 18F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma
- (2015) Dasiuke Izumi et al. JOURNAL OF GASTROENTEROLOGY
- Esophageal and Esophagogastric Junction Cancers, Version 1.2015
- (2015) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Fusobacterium nucleatumand T Cells in Colorectal Carcinoma
- (2015) Kosuke Mima et al. JAMA Oncology
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma
- (2014) T. Tahara et al. CANCER RESEARCH
- Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine
- (2014) Johan Vande Voorde et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma
- (2013) Hiroki Hara et al. CANCER SCIENCE
- Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
- (2013) Aleksandar D. Kostic et al. Cell Host & Microbe
- Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
- (2013) Mara Roxana Rubinstein et al. Cell Host & Microbe
- Oesophageal carcinoma
- (2013) Arjun Pennathur et al. LANCET
- Fusobacterium Is Associated with Colorectal Adenomas
- (2013) Amber N. McCoy et al. PLoS One
- Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
- (2011) M. Castellarin et al. GENOME RESEARCH
- Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
- (2011) Katrin M Sjoquist et al. LANCET ONCOLOGY
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- The regulation and function of Class III PI3Ks: novel roles for Vps34
- (2008) Jonathan M. Backer BIOCHEMICAL JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started